Welcome to LookChem.com Sign In|Join Free
  • or
ethyl (2-iodo-5-(1-methyl-5-oxopyrrolidin-2-yl)-4-((6-(methylsulfonyl)pyridin-3-yl)oxy)phenyl)carbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1616280-65-9

Post Buying Request

1616280-65-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1616280-65-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1616280-65-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,6,2,8 and 0 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1616280-65:
(9*1)+(8*6)+(7*1)+(6*6)+(5*2)+(4*8)+(3*0)+(2*6)+(1*5)=159
159 % 10 = 9
So 1616280-65-9 is a valid CAS Registry Number.

1616280-65-9Relevant academic research and scientific papers

Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus

Xu, Jiayi,Lin, Songnian,Myers, Robert W.,Addona, George,Berger, Joel P.,Campbell, Brian,Chen, Hsuan-shen,Chen, Zhesheng,Eiermann, George J.,Elowe, Nadine H.,Farrer, Brian T.,Feng, Wen,Fu, Qinghong,Kats-Kagan, Roman,Kavana, Michael,Malkani, Sunita,McMasters, Daniel R.,Mitra, Kaushik,Pachanski, Michele J.,Tong, Xinchun,Trujillo, Maria E.,Xu, Libo,Zhang, Bei,Zhang, Fengqi,Zhang, Rui,Parmee, Emma R.

, p. 2069 - 2073 (2017/04/10)

Glucokinase (GK, hexokinase IV) is a unique hexokinase that plays a central role in mammalian glucose homeostasis. Glucose phosphorylation by GK in the pancreatic β-cell is the rate-limiting step that controls glucose-stimulated insulin secretion. Similarly, GK-mediated glucose phosphorylation in hepatocytes plays a major role in increasing hepatic glucose uptake and metabolism and possibly lowering hepatic glucose output. Small molecule GK activators (GKAs) have been identified that increase enzyme activity by binding to an allosteric site. GKAs offer a novel approach for the treatment of Type 2 Diabetes Mellitus (T2DM) and as such have garnered much attention. We now report the design, synthesis, and biological evaluation of a novel series of 2,5,6-trisubstituted indole derivatives that act as highly potent GKAs. Among them, Compound 1 was found to possess high in vitro potency, excellent physicochemical properties, and good pharmacokinetic profile in rodents. Oral administration of Compound 1 at doses as low as 0.03?mg/kg led to robust blood glucose lowering efficacy in 3?week high fat diet-fed mice.

NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

-

Page/Page column 67, (2014/07/08)

Novel pyridine-2-carboxamide derivatives of formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are effective as glucokinase activating agents. Pharmaceutical compositions and methods of treatment are also included.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1616280-65-9